AT355725B - Verfahren zur herstellung stabiler loesungen - Google Patents

Verfahren zur herstellung stabiler loesungen

Info

Publication number
AT355725B
AT355725B AT390476A AT390476A AT355725B AT 355725 B AT355725 B AT 355725B AT 390476 A AT390476 A AT 390476A AT 390476 A AT390476 A AT 390476A AT 355725 B AT355725 B AT 355725B
Authority
AT
Austria
Prior art keywords
producing stable
stable solutions
solutions
producing
stable
Prior art date
Application number
AT390476A
Other languages
German (de)
English (en)
Other versions
ATA390476A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA390476A publication Critical patent/ATA390476A/de
Application granted granted Critical
Publication of AT355725B publication Critical patent/AT355725B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT390476A 1975-05-31 1976-05-28 Verfahren zur herstellung stabiler loesungen AT355725B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2524184 1975-05-31

Publications (2)

Publication Number Publication Date
ATA390476A ATA390476A (de) 1979-08-15
AT355725B true AT355725B (de) 1980-03-25

Family

ID=5947910

Family Applications (1)

Application Number Title Priority Date Filing Date
AT390476A AT355725B (de) 1975-05-31 1976-05-28 Verfahren zur herstellung stabiler loesungen

Country Status (26)

Country Link
JP (1) JPS585167B2 (pt)
AT (1) AT355725B (pt)
AU (1) AU508625B2 (pt)
BE (1) BE842348A (pt)
CA (1) CA1069438A (pt)
CS (1) CS205023B2 (pt)
DD (1) DD125597A5 (pt)
DK (1) DK154606C (pt)
ES (1) ES448372A1 (pt)
FI (1) FI761461A (pt)
FR (1) FR2313059A1 (pt)
GB (1) GB1539083A (pt)
GR (1) GR60264B (pt)
HK (1) HK15383A (pt)
HU (1) HU171514B (pt)
IE (1) IE42999B1 (pt)
IL (1) IL49668A (pt)
MY (1) MY8300013A (pt)
NL (1) NL172616C (pt)
NO (1) NO145262C (pt)
NZ (1) NZ180984A (pt)
PT (1) PT65151B (pt)
SE (1) SE426782B (pt)
SU (2) SU677664A3 (pt)
YU (1) YU133076A (pt)
ZA (1) ZA763138B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3227122A1 (de) * 1982-07-20 1984-01-26 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Stabile loesungen von mutterkornalkaloiden

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935515A1 (de) * 1979-09-03 1981-03-19 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Arzneipraeparat
FR2483235A1 (fr) * 1980-05-28 1981-12-04 Fabre Sa Pierre Compositions a usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinees au traitement des hyperseborrhees
HU192050B (en) * 1983-04-22 1987-05-28 Sandoz Ag Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist
IT1200609B (it) * 1985-04-04 1989-01-27 Poli Ind Chimica Spa Composizione farmaceutice per il trattamento delle turbe cerebrovascolari e del cervello anziano
DE102007014947B4 (de) 2007-03-23 2010-05-27 Axxonis Pharma Ag Stabilisierte wässrige Lösungen von Ergolinverbindungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD43402A (pt) *
US2033921A (en) * 1931-08-28 1936-03-17 Squibb & Sons Inc Solution of ergot alkaloids
US1969382A (en) * 1932-05-21 1934-08-07 Squibb & Sons Inc Preparation of a stable hydro-alcoholic extract of ergot

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3227122A1 (de) * 1982-07-20 1984-01-26 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Stabile loesungen von mutterkornalkaloiden

Also Published As

Publication number Publication date
FR2313059A1 (fr) 1976-12-31
JPS585167B2 (ja) 1983-01-29
HK15383A (en) 1983-05-20
YU133076A (en) 1984-08-31
DK228676A (da) 1976-12-01
CS205023B2 (en) 1981-04-30
ZA763138B (en) 1978-01-25
SU952106A3 (ru) 1982-08-15
GR60264B (en) 1978-04-20
JPS51144720A (en) 1976-12-13
NL172616C (nl) 1983-10-03
IL49668A0 (en) 1976-09-30
HU171514B (hu) 1978-01-28
SU677664A3 (ru) 1979-07-30
NL172616B (nl) 1983-05-02
CA1069438A (en) 1980-01-08
DK154606B (da) 1988-12-05
DD125597A5 (pt) 1977-05-04
ATA390476A (de) 1979-08-15
IE42999L (en) 1976-11-30
DK154606C (da) 1989-05-01
PT65151B (fr) 1978-02-06
NO145262B (no) 1981-11-09
NO761760L (pt) 1976-12-01
SE426782B (sv) 1983-02-14
GB1539083A (en) 1979-01-24
NO145262C (no) 1982-02-17
MY8300013A (en) 1983-12-31
PT65151A (fr) 1976-06-01
AU1442276A (en) 1977-12-01
FR2313059B1 (pt) 1978-12-15
NZ180984A (en) 1978-06-20
SE7605841L (sv) 1976-12-01
ES448372A1 (es) 1978-03-01
FI761461A (pt) 1976-12-01
IL49668A (en) 1979-10-31
IE42999B1 (en) 1980-12-03
BE842348A (fr) 1976-11-29
NL7605745A (nl) 1976-12-02
AU508625B2 (en) 1980-03-27

Similar Documents

Publication Publication Date Title
DD127900A5 (de) Verfahren zur herstellung von mercaptoazetidin-derivaten
AT363196B (de) Verfahren zur herstellung von androstan-17-on-derivaten
AT353251B (de) Verfahren zur herstellung von m- phenoxybenzaldehyd
AT352701B (de) Verfahren zur herstellung von m-phenoxybenzal- dehyd
AT358572B (de) Verfahren zur herstellung von 5-aroyl-1- niederalkyl-pyrrol-2-essigsaeure-derivaten
AT361140B (de) Verfahren zur herstellung optisch aktiver 11- -desoxy-16-aryloxy-omega-tetranorprostaglandine
AT358729B (de) Verfahren zur herstellung von 3-halogenmethyl-3 -cephemen
AT343905B (de) Verfahren zur herstellung von terpolymerisaten
AT352138B (de) Verfahren zur herstellung von 2-chlorsulfinyl- azetidin-4-onen
AT347437B (de) Verfahren zur herstellung von benzoylcyanid
AT352079B (de) Verfahren zur herstellung vanadiumarmer alkaliphosphatloesungen
AT348499B (de) Verfahren zur herstellung von aethylchlorthioformiat
AT347439B (de) Verfahren zur herstellung von benzoylcyanid
AT355725B (de) Verfahren zur herstellung stabiler loesungen
AT364817B (de) Verfahren zur herstellung von aminocyclolen
AT361639B (de) Verfahren zur herstellung von 5-androsten-17- -on-derivaten
AT347438B (de) Verfahren zur herstellung von benzoylcyanid
AT350582B (de) Verfahren zur herstellung von n-mehtyl-harn- stoffen
ATA310976A (de) Verfahren zur herstellung von pepropionsaeure
AT355013B (de) Verfahren zur herstellung von 2-oxo-pyrrolidin- n-alkylamiden
DD128610A5 (de) Verfahren zur herstellung substituierter phenoxypropanolamin-derivate
AT352910B (de) Verfahren zur herstellung von beta-mehtyl- digoxin
AT376633B (de) Verfahren zur herstellung von phosphornitriden
PT64875A (de) Verfahren zur herstellung von n-alenyl-2-aminomethyl-pyrrolidinen
ATA966976A (de) Verfahren zur herstellung von 2-aminoindanderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
EFA Change in the company name
ELA Expired due to lapse of time